Assessment of the Wide Field of View Provided by the SurroundScope

April 13, 2023 updated by: 270Surgical
The aim of this study is to assess the need and potential benefits of the wide field of view during general and gynecology laparoscopic surgery.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

The tremendous popularity of the laparoscopic surgeries is balanced with its tradeoffs - the needs for an excellent intracavitary visualization along with a surgeon skill set capable of performing these, often more technically challenging procedures. Image quality has improved, but there are still various restrictions to images captured by the lens at the tip of a long tubular laparoscope.

270Surgical developed a 270 degree angle scope to overcome these unmet needs and improve the image quantity and extent during laparoscopy. The study will evaluate standard laparoscopic surgery using the 270Surgical system; "The SurroundScope".

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Age greater than or equal to 18
  2. Capable of giving informed consent
  3. Scheduled for general or gynecology laparoscopic surgery or open procedure that in the surgeon's opinion can be performed laparoscopically with the 270System

Exclusion Criteria:

  1. Unfit for surgery: concomitant disorders incompatible with the study or surgery (at the discretion of the investigator)
  2. Patients with contraindications to undergo surgery
  3. Patients with ASA class* >3
  4. Advanced cirrhosis with failure of hepatic function
  5. Patients who have participated in another interventional clinical study in the last month
  6. Pregnancy
  7. Unable to consent (due to cultural, language or neurological barriers)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: SurroundScope
For laparoscopic camera system, the SurroundScope. 270-degree angle videoscope (270Surgical, Israel) was used
The study will evaluate standard laparoscopic surgery using the 270Surgical system. The procedure will be performed according to the institution's standard of care, using the SurroundScope for visualization.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessment of the need and potential benefits of the wide field of view
Time Frame: Day of surgery
Assessed by a multi-question subjective questionnaire completed in the OR, immediately after the case, by the surgeon and the camera person and constructed on a Likert-type, 5-point scale (1=Strongly disagree, 2=Disagree, 3=Neither agree or disagree, 4=Agree, 5=Strongly agree).
Day of surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessment of the 270 Lenses clearance contribution to the procedure.
Time Frame: Day of surgery

Lenses clearance contribution will be assessed by:

Rating of the visual impairment due to smoke using a likert-type scale of 1-5: 1=imperceptible, 2= perceptible but not interfering, 3=same as in standard procedure, 4=annoying, 5=Very annoying.

Day of surgery
Assessment of the 270 Lenses clearance contribution to the procedure.
Time Frame: Day of surgery

Lenses clearance contribution will be assessed by:

Amount of removals and pauses for fog and smoke incidences using a scale of 1-5: 1=none, 2= less than in standard procedure, 3=same as in standard procedure, 4= more than in standard procedure, 5=much more than in standard procedure.

Day of surgery
A record of complications related to the SurroundScope
Time Frame: Day of surgery up to 2 weeks after the surgical procedure
The SurroundScope related operative complications, that require further clinical intervention
Day of surgery up to 2 weeks after the surgical procedure

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Additional measurements - timing, compared to retrospective data of matched anonymous 100 patients' data from the medical records of the hospital.
Time Frame: day of surgery
Measuring time of laparoscopic procedure (lap inserted to final lap removal)
day of surgery
Additional measurements- Intraoperative events
Time Frame: day of surgery
Measurements include collecting a log of events that could have been missed with standard scope and were captured in the side screens
day of surgery
Additional measurements - lengs of stay, compared to retrospective data of matched anonymous 100 patients' data from the medical records of the hospital.
Time Frame: Up to two weeks
Number of days patients stayed at the hospital following the operation
Up to two weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Gideon Sroka, MD, Bnai Zion Medical Center, 47 Golomb St. Haifa, 31048, Israel

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 9, 2020

Primary Completion (Anticipated)

September 1, 2023

Study Completion (Anticipated)

December 30, 2023

Study Registration Dates

First Submitted

November 17, 2020

First Submitted That Met QC Criteria

November 25, 2020

First Posted (Actual)

December 3, 2020

Study Record Updates

Last Update Posted (Actual)

April 14, 2023

Last Update Submitted That Met QC Criteria

April 13, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • CL 0334

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Laparoscopic Surgery

Clinical Trials on SurroundScope

3
Subscribe